What is CAR T-cell therapy?

An overview is provided of chimeric antigen receptor (CAR) T-cell therapy which uses the patient’s immune system to fight cancer. 2 CAR T-cell therapy products are approved in the EU. Most evidence is from small single-arm open label studies with limited survival follow-up data.

Source:

Drug and Therapeutics Bulletin